# A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).

> clinical trial · VERIFIED · 2026-07-31

Status: NOT_YET_RECRUITING · Sponsor: Sapience Therapeutics · Condition: Familial Adenomatous Polyposis (FAP)

- Company: Sapience Therapeutics
- Sector: Familial Adenomatous Polyposis (FAP)
- Primary source: https://clinicaltrials.gov/study/NCT07729371

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.